| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.967 | 0.002 | 0.967 | Transcription factor NF kappa B inhibitor | 0.956 0.003 DBMET02501 0.967 0.002 DBMET02502 | ||
| 0.963 | 0.001 | 0.963 | Anesthetic general | 0.876 0.002 DBMET02501 0.963 0.001 DBMET02502 | ||
| 0.94 | 0.003 | 0.94 | Cardiotonic | 0.889 0.004 DBMET02501 0.94 0.003 DBMET02502 | ||
| 0.932 | 0 | 0.932 | Na+ K+ transporting ATPase inhibitor | 0.917 0 DBMET02501 0.932 0 DBMET02502 | ||
| 0.931 | 0.005 | 0.931 | Apoptosis agonist | 0.923 0.005 DBMET02501 0.931 0.005 DBMET02502 | ||
| 0.889 | 0.003 | 0.889 | DNA damaging | 0.877 0.003 DBMET02501 0.889 0.003 DBMET02502 | ||
| 0.885 | 0.002 | 0.885 | Diuretic | 0.737 0.003 DBMET02501 0.885 0.002 DBMET02502 | ||
| 0.868 | 0.002 | 0.868 | Hypoxia-inducible factor 1 alpha inhibitor | 0.792 0.003 DBMET02501 0.868 0.002 DBMET02502 | ||
| 0.775 | 0.004 | 0.798 | Caspase 3 stimulant | 0.798 0.004 DBMET02501 0.775 0.004 DBMET02502 | DBMET02501 | |
| 0.765 | 0.02 | 0.811 | Antiinflammatory | 0.811 0.014 DBMET02501 0.765 0.02 DBMET02502 | DBMET02501 | |
| 0.747 | 0.005 | 0.769 | Cholesterol antagonist | 0.769 0.005 DBMET02501 0.747 0.005 DBMET02502 | DBMET02501 | |
| 0.673 | 0.002 | 0.673 | ATPase inhibitor | 0.481 0.003 DBMET02501 0.673 0.002 DBMET02502 | ||
| 0.671 | 0.003 | 0.671 | Transcription factor STAT inhibitor | 0.513 0.007 DBMET02501 0.671 0.003 DBMET02502 | ||
| 0.654 | 0.003 | 0.654 | Transcription factor STAT3 inhibitor | 0.522 0.005 DBMET02501 0.654 0.003 DBMET02502 | ||
| 0.661 | 0.012 | 0.707 | Antibacterial | 0.707 0.008 DBMET02501 0.661 0.012 DBMET02502 | DBMET02501 | |
| 0.633 | 0.008 | 0.71 | Nitric oxide antagonist | 0.71 0.005 DBMET02501 0.633 0.008 DBMET02502 | DBMET02501 | |
| 0.632 | 0.009 | 0.644 | Immunosuppressant | 0.644 0.008 DBMET02501 0.632 0.009 DBMET02502 | DBMET02501 | |
| 0.585 | 0.018 | 0.585 | Immunostimulant | 0.561 0.021 DBMET02501 0.585 0.018 DBMET02502 | ||
| 0.526 | 0.017 | 0.578 | Apoptosis antagonist | 0.578 0.012 DBMET02501 0.526 0.017 DBMET02502 | DBMET02501 | |
| 0.491 | 0.004 | 0.535 | Antineoplastic antibiotic | 0.535 0.004 DBMET02501 0.491 0.004 DBMET02502 | DBMET02501 | |
| 0.489 | 0.007 | 0.489 | Interferon gamma antagonist | 0.473 0.007 DBMET02501 0.489 0.007 DBMET02502 | ||
| 0.464 | 0.011 | 0.464 | P-glycoprotein inhibitor | 0.431 0.013 DBMET02501 0.464 0.011 DBMET02502 | ||
| 0.501 | 0.059 | 0.531 | Caspase 9 stimulant | 0.531 0.049 DBMET02501 0.501 0.059 DBMET02502 | DBMET02501 | |
| 0.449 | 0.008 | 0.458 | Sodium/bile acid cotransporter inhibitor | 0.458 0.006 DBMET02501 0.449 0.008 DBMET02502 | DBMET02501 | |
| 0.444 | 0.005 | 0.452 | Interleukin 6 antagonist | 0.452 0.005 DBMET02501 0.444 0.005 DBMET02502 | DBMET02501 | |
| 0.446 | 0.01 | 0.541 | Hepatoprotectant | 0.541 0.005 DBMET02501 0.446 0.01 DBMET02502 | DBMET02501 | |
| 0.453 | 0.026 | 0.473 | Antioxidant | 0.473 0.023 DBMET02501 0.453 0.026 DBMET02502 | DBMET02501 | |
| 0.43 | 0.017 | 0.447 | Angiogenesis stimulant | 0.447 0.016 DBMET02501 0.43 0.017 DBMET02502 | DBMET02501 | |
| 0.39 | 0.009 | 0.402 | Lipocortins synthesis antagonist | 0.402 0.008 DBMET02501 0.39 0.009 DBMET02502 | DBMET02501 | |
| 0.384 | 0.005 | 0.406 | Cholesterol synthesis inhibitor | 0.406 0.004 DBMET02501 0.384 0.005 DBMET02502 | DBMET02501 | |
| 0.382 | 0.011 | 0.566 | Topoisomerase II inhibitor | 0.566 0.005 DBMET02501 0.382 0.011 DBMET02502 | DBMET02501 | |
| 0.375 | 0.009 | 0.389 | Peptidyltransferase inhibitor | 0.389 0.008 DBMET02501 0.375 0.009 DBMET02502 | DBMET02501 | |
| 0.366 | 0.014 | 0.404 | Melanin inhibitor | 0.404 0.012 DBMET02501 0.366 0.014 DBMET02502 | DBMET02501 | |
| 0.355 | 0.029 | 0.377 | DNA synthesis inhibitor | 0.377 0.025 DBMET02501 0.355 0.029 DBMET02502 | DBMET02501 | |
| 0.343 | 0.024 | 0.363 | Growth hormone agonist | 0.363 0.021 DBMET02501 0.343 0.024 DBMET02502 | DBMET02501 | |
| 0.32 | 0.009 | 0.374 | Topoisomerase I inhibitor | 0.374 0.006 DBMET02501 0.32 0.009 DBMET02502 | DBMET02501 | |
| 0.307 | 0.012 | 0.421 | Alkylator | 0.421 0.007 DBMET02501 0.307 0.012 DBMET02502 | DBMET02501 | |
| 0.335 | 0.041 | 0.335 | Hypoglycemic | 0.271 0.065 DBMET02501 0.335 0.041 DBMET02502 | ||
| 0.325 | 0.04 | 0.325 | Vasodilator | 0.301 0.048 DBMET02501 0.325 0.04 DBMET02502 | ||
| 0.286 | 0.015 | 0.286 | Adenylate cyclase inhibitor | 0.146 0.048 DBMET02501 0.286 0.015 DBMET02502 | ||
| 0.257 | 0.003 | 0.257 | Glycine receptor agonist | 0.249 0.003 DBMET02501 0.257 0.003 DBMET02502 | ||
| 0.326 | 0.074 | 0.405 | Antithrombotic | 0.405 0.048 DBMET02501 0.326 0.074 DBMET02502 | DBMET02501 | |
| 0.298 | 0.052 | 0.298 | Free radical scavenger | 0.27 0.06 DBMET02501 0.298 0.052 DBMET02502 | ||
| 0.254 | 0.008 | 0.273 | Selectin antagonist | 0.273 0.007 DBMET02501 0.254 0.008 DBMET02502 | DBMET02501 | |
| 0.256 | 0.015 | 0.275 | DNA intercalator | 0.275 0.014 DBMET02501 0.256 0.015 DBMET02502 | DBMET02501 | |
| 0.274 | 0.038 | 0.274 | RNA-directed DNA polymerase inhibitor | 0.232 0.063 DBMET02501 0.274 0.038 DBMET02502 | ||
| 0.229 | 0.004 | 0.274 | Protein 50S ribosomal subunit inhibitor | 0.274 0.003 DBMET02501 0.229 0.004 DBMET02502 | DBMET02501 | |
| 0.245 | 0.029 | 0.245 | Amylase inhibitor | 0.194 0.046 DBMET02501 0.245 0.029 DBMET02502 | ||
| 0.242 | 0.029 | 0.242 | Protein kinase stimulant | 0.237 0.03 DBMET02501 0.242 0.029 DBMET02502 | ||
| 0.289 | 0.082 | 0.3 | Interleukin 2 agonist | 0.3 0.074 DBMET02501 0.289 0.082 DBMET02502 | DBMET02501 | |
| 0.216 | 0.01 | 0.216 | Antineoplastic alkaloid | 0.198 0.014 DBMET02501 0.216 0.01 DBMET02502 | ||
| 0.267 | 0.067 | 0.318 | Tumour necrosis factor alpha release inhibitor | 0.318 0.047 DBMET02501 0.267 0.067 DBMET02502 | DBMET02501 | |
| 0.215 | 0.018 | 0.215 | Farnesoid X receptor antagonist | 0.192 0.024 DBMET02501 0.215 0.018 DBMET02502 | ||
| 0.212 | 0.017 | 0.265 | Microtubule formation inhibitor | 0.265 0.005 DBMET02501 0.212 0.017 DBMET02502 | DBMET02501 | |
| 0.201 | 0.015 | 0.301 | Topoisomerase II alpha inhibitor | 0.301 0.007 DBMET02501 0.201 0.015 DBMET02502 | DBMET02501 | |
| 0.203 | 0.02 | 0.203 | Expectorant | 0.174 0.027 DBMET02501 0.203 0.02 DBMET02502 | ||
| 0.232 | 0.05 | 0.232 | Neurotrophic factor enhancer | 0.211 0.066 DBMET02501 0.232 0.05 DBMET02502 | ||
| 0.245 | 0.07 | 0.369 | Hypolipemic | 0.369 0.031 DBMET02501 0.245 0.07 DBMET02502 | DBMET02501 | |
| 0.178 | 0.005 | 0.178 | Bile acid receptor antagonist | 0.167 0.005 DBMET02501 0.178 0.005 DBMET02502 | ||
| 0.181 | 0.011 | 0.186 | Transcription factor NF kappa B stimulant | 0.186 0.01 DBMET02501 0.181 0.011 DBMET02502 | DBMET02501 | |
| 0.177 | 0.008 | 0.193 | Anabolic | 0.193 0.005 DBMET02501 0.177 0.008 DBMET02502 | DBMET02501 | |
| 0.218 | 0.062 | 0.23 | Platelet adhesion inhibitor | 0.23 0.056 DBMET02501 0.218 0.062 DBMET02502 | DBMET02501 | |
| 0.166 | 0.018 | 0.166 | Androgen antagonist | 0.081 0.065 DBMET02501 0.166 0.018 DBMET02502 | ||
| 0.154 | 0.007 | 0.19 | Glycine receptor antagonist | 0.19 0.004 DBMET02501 0.154 0.007 DBMET02502 | DBMET02501 | |
| 0.151 | 0.004 | 0.265 | RNA-directed RNA polymerase stimulant | 0.265 0.002 DBMET02501 0.151 0.004 DBMET02502 | DBMET02501 | |
| 0.148 | 0.011 | 0.172 | Estrogen agonist | 0.172 0.01 DBMET02501 0.148 0.011 DBMET02502 | DBMET02501 | |
| 0.181 | 0.048 | 0.181 | Insulin secretagoues | 0.159 0.065 DBMET02501 0.181 0.048 DBMET02502 | ||
| 0.157 | 0.024 | 0.157 | AMP-activated protein kinase stimulant | 0.122 0.047 DBMET02501 0.157 0.024 DBMET02502 | ||
| 0.166 | 0.036 | 0.166 | Cyclooxygenase 3 inhibitor | 0.135 0.062 DBMET02501 0.166 0.036 DBMET02502 | ||
| 0.137 | 0.011 | 0.137 | ATPase (Vacuolar H+) inhibitor | 0.136 0.012 DBMET02501 0.137 0.011 DBMET02502 | ||
| 0.14 | 0.027 | 0.146 | Toll-Like receptor 4 antagonist | 0.146 0.023 DBMET02501 0.14 0.027 DBMET02502 | DBMET02501 | |
| 0.111 | 0.011 | 0.121 | Androgen agonist | 0.121 0.01 DBMET02501 0.111 0.011 DBMET02502 | DBMET02501 | |
| 0.147 | 0.05 | 0.153 | Ca2+-transporting ATPase inhibitor | 0.153 0.036 DBMET02501 0.147 0.05 DBMET02502 | DBMET02501 | |
| 0.208 | 0.113 | 0.208 | Spasmolytic | 0.208 0.113 DBMET02502 | ||
| 0.131 | 0.037 | 0.133 | Estrogen antagonist | 0.133 0.035 DBMET02501 0.131 0.037 DBMET02502 | DBMET02501 | |
| 0.275 | 0.185 | 0.359 | Cyclophilin D inhibitor | 0.359 0.116 DBMET02501 0.275 0.185 DBMET02502 | DBMET02501 | |
| 0.15 | 0.072 | 0.211 | NOS3 expression enhancer | 0.211 0.037 DBMET02501 0.15 0.072 DBMET02502 | DBMET02501 | |
| 0.083 | 0.012 | 0.086 | Lipocortins synthesis agonist | 0.086 0.01 DBMET02501 0.083 0.012 DBMET02502 | DBMET02501 | |
| 0.083 | 0.012 | 0.083 | H+/K+-transporting ATPase inhibitor | 0.056 0.029 DBMET02501 0.083 0.012 DBMET02502 | ||
| 0.128 | 0.062 | 0.144 | DNA polymerase I inhibitor | 0.144 0.052 DBMET02501 0.128 0.062 DBMET02502 | DBMET02501 | |
| 0.141 | 0.078 | 0.155 | Adenylate cyclase stimulant | 0.155 0.054 DBMET02501 0.141 0.078 DBMET02502 | DBMET02501 | |
| 0.065 | 0.01 | 0.072 | Microtubule stabilization | 0.072 0.005 DBMET02501 0.065 0.01 DBMET02502 | DBMET02501 | |
| 0.061 | 0.008 | 0.067 | Antibiotic Aminoglycoside-like | 0.067 0.007 DBMET02501 0.061 0.008 DBMET02502 | DBMET02501 | |
| 0.132 | 0.079 | 0.132 | Neurotrophic factor | 0.118 0.098 DBMET02501 0.132 0.079 DBMET02502 | ||
| 0.057 | 0.008 | 0.06 | Glucose-6-phosphate dehydrogenase inhibitor | 0.06 0.007 DBMET02501 0.057 0.008 DBMET02502 | DBMET02501 | |
| 0.077 | 0.029 | 0.14 | Aromatase inhibitor | 0.14 0.014 DBMET02501 0.077 0.029 DBMET02502 | DBMET02501 | |
| 0.205 | 0.158 | 0.205 | Immunomodulator | 0.205 0.158 DBMET02502 | ||
| 0.128 | 0.085 | 0.144 | Lipid peroxidase inhibitor | 0.144 0.073 DBMET02501 0.128 0.085 DBMET02502 | DBMET02501 | |
| 0.051 | 0.008 | 0.06 | Protein 30S ribosomal subunit inhibitor | 0.06 0.006 DBMET02501 0.051 0.008 DBMET02502 | DBMET02501 | |
| 0.14 | 0.1 | 0.156 | Arachidonic acid antagonist | 0.156 0.082 DBMET02501 0.14 0.1 DBMET02502 | DBMET02501 | |
| 0.044 | 0.006 | 0.071 | Motilin receptor agonist | 0.071 0.005 DBMET02501 0.044 0.006 DBMET02502 | DBMET02501 | |
| 0.052 | 0.017 | 0.064 | Estrogen receptor alpha agonist | 0.064 0.014 DBMET02501 0.052 0.017 DBMET02502 | DBMET02501 | |
| 0.109 | 0.075 | 0.115 | Cell adhesion inhibitor | 0.115 0.069 DBMET02501 0.109 0.075 DBMET02502 | DBMET02501 | |
| 0.048 | 0.019 | 0.053 | Estrogen receptor beta agonist | 0.053 0.019 DBMET02501 0.048 0.019 DBMET02502 | DBMET02501 | |
| 0.029 | 0.004 | 0.04 | Antibiotic Macrolide-like | 0.04 0.004 DBMET02501 0.029 0.004 DBMET02502 | DBMET02501 | |
| 0.043 | 0.022 | 0.043 | 5-Alpha-reductase inhibitor | 0.041 0.023 DBMET02501 0.043 0.022 DBMET02502 | ||
| 0.024 | 0.005 | 0.025 | Telomerase stimulant | 0.025 0.004 DBMET02501 0.024 0.005 DBMET02502 | DBMET02501 | |
| 0.038 | 0.019 | 0.039 | Glucocorticoid antagonist | 0.039 0.019 DBMET02501 0.038 0.019 DBMET02502 | DBMET02501 | |
| 0.057 | 0.039 | 0.061 | Acetyl-CoA transferase 2 inhibitor | 0.061 0.029 DBMET02501 0.057 0.039 DBMET02502 | DBMET02501 | |
| 0.097 | 0.081 | 0.097 | Protein-tyrosine phosphatase 1B inhibitor | 0.097 0.081 DBMET02502 | ||
| 0.08 | 0.066 | 0.08 | T cell inhibitor | 0.08 0.066 DBMET02502 | ||
| 0.035 | 0.023 | 0.046 | Tubulin agonist | 0.046 0.01 DBMET02501 0.035 0.023 DBMET02502 | DBMET02501 | |
| 0.095 | 0.085 | 0.111 | Mucolytic | 0.111 0.064 DBMET02501 0.095 0.085 DBMET02502 | DBMET02501 | |
| 0.021 | 0.014 | 0.022 | Corticosteroid-like | 0.022 0.014 DBMET02501 0.021 0.014 DBMET02502 | DBMET02501 | |
| 0.089 | 0.085 | 0.089 | Estrogen receptor beta antagonist | 0.089 0.085 DBMET02502 | ||
| 0.016 | 0.014 | 0.016 | Progesterone agonist | 0.016 0.014 DBMET02501 0.016 0.014 DBMET02502 | ||
| 0.158 | 0.16 | 0.191 | Interleukin agonist | 0.191 0.129 DBMET02501 | DBMET02501 | |
| 0.03 | 0.035 | 0.043 | HMG CoA reductase inhibitor | 0.043 0.011 DBMET02501 | DBMET02501 | |
| 0.051 | 0.068 | 0.073 | Phosphofructokinase-1 inhibitor | 0.073 0.046 DBMET02501 | DBMET02501 | |
| 0.06 | 0.079 | 0.076 | CDC25A inhibitor | 0.076 0.048 DBMET02501 | DBMET02501 | |
| 0.174 | 0.203 | 0.217 | Angiogenesis inhibitor | 0.217 0.151 DBMET02501 | DBMET02501 | |
| 0.078 | 0.107 | 0.086 | Interleukin 12 antagonist | 0.086 0.081 DBMET02501 | DBMET02501 | |
| 0.122 | 0.158 | 0.303 | Antimitotic | 0.303 0.043 DBMET02501 | DBMET02501 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |